Annual CFF
$118.12 M
+$33.80 M+40.08%
December 31, 2023
Summary
- As of February 12, 2025, FULC annual cash flow from financing activities is $118.12 million, with the most recent change of +$33.80 million (+40.08%) on December 31, 2023.
- During the last 3 years, FULC annual CFF has risen by +$46.99 million (+66.06%).
- FULC annual CFF is now -36.67% below its all-time high of $186.51 million, reached on December 31, 2021.
Performance
FULC Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$635.00 K
+$258.00 K+68.44%
September 30, 2024
Summary
- As of February 12, 2025, FULC quarterly cash flow from financing activities is $635.00 thousand, with the most recent change of +$258.00 thousand (+68.44%) on September 30, 2024.
- Over the past year, FULC quarterly CFF has increased by +$348.00 thousand (+121.25%).
- FULC quarterly CFF is now -99.54% below its all-time high of $137.90 million, reached on September 30, 2021.
Performance
FULC Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$2.95 M
+$635.00 K+27.43%
September 30, 2024
Summary
- As of February 12, 2025, FULC TTM cash flow from financing activities is $2.95 million, with the most recent change of +$635.00 thousand (+27.43%) on September 30, 2024.
- Over the past year, FULC TTM CFF has dropped by -$115.17 million (-97.50%).
- FULC TTM CFF is now -98.54% below its all-time high of $201.67 million, reached on March 31, 2023.
Performance
FULC TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
FULC Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +40.1% | +121.3% | -97.5% |
| 3 y3 years | +66.1% | +121.3% | -97.5% |
| 5 y5 years | +12.5% | +121.3% | -97.5% |
FULC Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -36.7% | +40.1% | -99.5% | -100.0% | -98.5% | +41.8% |
| 5 y | 5-year | -36.7% | +83.6% | -99.5% | +326.0% | -98.5% | +41.8% |
| alltime | all time | -36.7% | +568.8% | -99.5% | +220.0% | -98.5% | +41.8% |
Fulcrum Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $635.00 K(+68.4%) | $2.95 M(+27.4%) |
| Jun 2024 | - | $377.00 K(-77.2%) | $2.31 M(+11.3%) |
| Mar 2024 | - | $1.65 M(+475.3%) | $2.08 M(-98.2%) |
| Dec 2023 | $118.12 M(+40.1%) | $287.00 K(>+9900.0%) | $118.12 M(+0.1%) |
| Sep 2023 | - | $0.00(-100.0%) | $118.05 M(-40.7%) |
| Jun 2023 | - | $142.00 K(-99.9%) | $199.00 M(-1.3%) |
| Mar 2023 | - | $117.69 M(>+9900.0%) | $201.67 M(+139.2%) |
| Dec 2022 | $84.32 M(-54.8%) | $218.00 K(-99.7%) | $84.32 M(-0.8%) |
| Sep 2022 | - | $80.95 M(+2779.6%) | $85.00 M(-40.1%) |
| Jun 2022 | - | $2.81 M(+707.8%) | $141.95 M(+1.9%) |
| Mar 2022 | - | $348.00 K(-60.9%) | $139.35 M(-25.3%) |
| Dec 2021 | $186.51 M | $891.00 K(-99.4%) | $186.51 M(-2.8%) |
| Sep 2021 | - | $137.90 M(>+9900.0%) | $191.87 M(+256.1%) |
| Jun 2021 | - | $209.00 K(-99.6%) | $53.88 M(-54.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $47.50 M(+659.5%) | $118.36 M(+66.4%) |
| Dec 2020 | $71.13 M(+10.6%) | $6.25 M(-7636.1%) | $71.13 M(+10.1%) |
| Sep 2020 | - | -$83.00 K(-100.1%) | $64.60 M(-50.3%) |
| Jun 2020 | - | $64.69 M(>+9900.0%) | $129.88 M(+100.9%) |
| Mar 2020 | - | $274.00 K(-197.5%) | $64.66 M(+0.5%) |
| Dec 2019 | $64.34 M(-38.7%) | -$281.00 K(-100.4%) | $64.34 M(-0.3%) |
| Sep 2019 | - | $65.20 M(<-9900.0%) | $64.53 M(-18.5%) |
| Jun 2019 | - | -$529.00 K(+1025.5%) | $79.16 M(-14.3%) |
| Mar 2019 | - | -$47.00 K(-47.8%) | $92.34 M(-12.1%) |
| Dec 2018 | $105.03 M(+494.6%) | -$90.00 K(-100.1%) | $105.03 M(-0.1%) |
| Sep 2018 | - | $79.83 M(+531.0%) | $105.11 M(+315.6%) |
| Jun 2018 | - | $12.65 M(+0.1%) | $25.29 M(+100.1%) |
| Mar 2018 | - | $12.64 M | $12.64 M |
| Dec 2017 | $17.66 M | - | - |
FAQ
- What is Fulcrum Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Fulcrum Therapeutics?
- What is Fulcrum Therapeutics annual CFF year-on-year change?
- What is Fulcrum Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Fulcrum Therapeutics?
- What is Fulcrum Therapeutics quarterly CFF year-on-year change?
- What is Fulcrum Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Fulcrum Therapeutics?
- What is Fulcrum Therapeutics TTM CFF year-on-year change?
What is Fulcrum Therapeutics annual cash flow from financing activities?
The current annual CFF of FULC is $118.12 M
What is the all time high annual CFF for Fulcrum Therapeutics?
Fulcrum Therapeutics all-time high annual cash flow from financing activities is $186.51 M
What is Fulcrum Therapeutics annual CFF year-on-year change?
Over the past year, FULC annual cash flow from financing activities has changed by +$33.80 M (+40.08%)
What is Fulcrum Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of FULC is $635.00 K
What is the all time high quarterly CFF for Fulcrum Therapeutics?
Fulcrum Therapeutics all-time high quarterly cash flow from financing activities is $137.90 M
What is Fulcrum Therapeutics quarterly CFF year-on-year change?
Over the past year, FULC quarterly cash flow from financing activities has changed by +$348.00 K (+121.25%)
What is Fulcrum Therapeutics TTM cash flow from financing activities?
The current TTM CFF of FULC is $2.95 M
What is the all time high TTM CFF for Fulcrum Therapeutics?
Fulcrum Therapeutics all-time high TTM cash flow from financing activities is $201.67 M
What is Fulcrum Therapeutics TTM CFF year-on-year change?
Over the past year, FULC TTM cash flow from financing activities has changed by -$115.17 M (-97.50%)